Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Testicular Neoplasms 4Testicular Germ Cell Tumor 3Sarcoma 3Central Nervous System Neoplasms 3Teratoma 2Rhabdoid Tumor 2Ovarian Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Germ Cell and Embryonal 2Medulloblastoma 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Wilms Tumor 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Prostatic Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroblastoma 1Nephroma, Mesoblastic 1Neoplasms, Unknown Primary 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Filgrastim 2Docetaxel 2etoposide phosphate 1entinostat 1Thalidomide 1Peripheral Blood Stem Cell Transplantation 1Ifosfamide 1Gemcitabine 1Etoposide 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
AIDS-related Kaposi sarcoma × etoposide phosphate × Genitourinary × Clear all
NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡